Law Would Stem Drug Shortages Bucshon's Bill Requires FDA to Police Makers

Evansville Courier & Press (2007-Current), February 12, 2012 | Go to article overview

Law Would Stem Drug Shortages Bucshon's Bill Requires FDA to Police Makers


WASHINGTON - Shortages of prescription drugs, particularly those designed to aid cancer patients, are reaching a critical stage, and Indiana Eighth District Rep. Larry Bucshon is determined to do something about it. In an unusual act of bipartisanship, at least for the 112th Congress, Bucshon, a Republican from Newburgh, has teamed up with Rep. John Carney, DDel., to sponsor legislation aimed at cutting off potential shortages before they take root.

The legislation, titled the Drug Shortage Prevention Act of 2012, was introduced Jan. 31 and assigned to the House Energy and Commerce Committee and the House Judiciary Committee to study various provisions.

Bucshon, a heart surgeon before winning the Southwestern Indiana congressional seat in 2010, said drug shortages for patients in need of specialized care is a subject of national importance that constitutes "a critical issue that deals directly with the well- being of our citizens."

"It is vital that we are proactive when it comes to preventing shortages and ensuring access to treatments that save lives and improve health," he said. Obama administration officials maintain prescription drug shortages remain relatively rare but acknowledge the problem is growing, particularly as it pertains to unique drugs without good alternatives.

Dr. Margaret Hamburg, commissioner of the U.S. Food and Drug Administration, reported that the number of drug shortages tripled from 61 in 2005 to 178 in 2010 before hopping up to 230 instances last year. "Some of these shortages delay or deny needed care for patients since they involve critical drugs used to treat cancer, to provide required nutrition or to address other serious conditions," Hamburg said. The picture is actually a bit worse than those numbers make it appear.

In a report issued in October, "A Review of FDA's Approach to Medical Product Shortages," it was revealed the FDA had to step in to prevent 137 additional shortages from Jan. 1, 2010, onward. Drug shortages, the report stated, "have been increasing in frequency and severity in recent years and adversely affecting patient care."

"Some recent shortages have involved drugs for life-threatening conditions and, in some cases, the product in shortage has been the only product for the patient's condition," the report said. "While most drugs do not experience shortages, this is a significant public health problem, one that deserves the concerted attention of government and industry."

Most of the problem comes in the area of sterile injectable drugs. Of 127 cases studied in 2010-2011, according to the FDA, sterile injectables accounted for 80 percent of the shortage.

This carries an impact on the sensitive area of cancer treatment - data indicate the use of sterile injectable cancer treatments has increased by about 20 percent over the past five years without a corresponding increase in production capacity. The major therapeutic classes of drugs facing shortages are oncology drugs, 28 percent, antibiotics, 13 percent, and elect rolyte/nut r it ion drugs, 11 percent. Several factors play into the shortages. "The reasons behind these trends are not hard to find," said Dr. Douglas Throckmorton, deputy director of the FDA's Center for Drug Evaluation and Research.

"Economic forces, industry consolidation, manufacturing challenges such as manufacturing quality, discontinuations, and capacity issues. All are playing into a larger spectrum to cause drug shortages to grow worse and not better." The shortages, Throckmorton said, matter. "They are the injectables," he said. "They are the things that we understand to be most important for public health.

They are things that we need to address or things we need to find a way to turn around. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Law Would Stem Drug Shortages Bucshon's Bill Requires FDA to Police Makers
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.